Table 4.
The comparison of mean score of quality of life in the three groups
| SF36 two main domains | Control group (n=85) | Gabapentin group (n=86) | Celecoxib group (n=87) | P 2 |
|---|---|---|---|---|
| Physical health | ||||
| Preoperative | 38.97±4.52 | 39.41±3.94 | 39.55±4.32 | 0.651 |
| 1 month | 89.99±4.97a | 89.94±4.93a | 91.11±3.74b | 0.044 |
| P 1 | <0.001 | <0.001 | <0.001 | |
| Mental health | ||||
| Preoperative | 87.57±15.49 | 86.94±15.38 | 91.07±11.40 | 0.121 |
| 1 month | 89.29±12.82 | 88.38±13.53 | 92.09±9.87 | 0.702 |
| P 1 | <0.001 | <0.001 | 0.068 |
P1=Resulted from paired samples t-test for within group comparisons; P2=Resulted from ANCOVA for between group comparisons; adjustment was made for baseline quality of life; ANCOVA=Analysis of covariance; SF36=36 item short form health survey